Table 2.
Patient comorbidities at diagnosis
| Patient comorbidities | 2008–2009 | 2018–2019 | p value |
|---|---|---|---|
| Total number of patients with any comorbidity, n (%)* | 99 (76.7) | 136 (84.5) | 0.07 |
| Hypertension, n (%) | 66 (51.2) | 88 (54.7) | 0.32 |
| Myocardial infarction, n (%) | 17 (13.2) | 14 (8.7) | 0.22 |
| Congestive heart failure, n (%) | 13 (10.1) | 25 (15.5) | 0.17 |
| Peripheral vascular disease, n (%) | 10 (7.8) | 6 (3.7) | 0.14 |
| Stroke/TIA, n (%) | 7 (5.4) | 6 (3.7) | 0.49 |
| Hemi/paraplegia, n (%) | 3 (2.3) | 4 (2.5) | 0.93 |
| Diabetes, n (%) | 23 (17.8) | 29 (18) | 0.97 |
| COPD/Asthma, n (%) | 17 (13.2) | 26 (16.1) | 0.48 |
| Renal disease, n (%) | 6 (4.7) | 14 (8.7) | 0.18 |
| Peptic ulcer disease, n (%) | 2 (1.6) | 6 (3.7) | 0.26 |
| Cancer without metastases, n (%) | 15 (11.6) | 38 (23.6) | 0.009 |
| Cancer with metastases, n (%) | 4 (3.1) | 12 (7.5) | 0.11 |
| Rheumatic disease, n (%) | 9 (7) | 15 (9.3) | 0.47 |
| Depression, n (%) | 18 (14) | 15 (9.3) | 0.22 |
| Dementia, n (%) | 7 (5.4) | 8 (5.0) | 0.86 |
| On warfarin, n (%) | 10 (7.3) | 6 (3.7) | 0.14 |
*Each individual may be diagnosed with several of the below mentioned comorbidities